Authors:
JUNGNELIUS U
RINGBORG U
AAMDAL S
MATTSSON J
STIERNER U
INGVAR C
MALMSTROM P
ANDERSSON R
KARLSSON M
WILLMAN K
WIST E
BJELKENGREN G
WESTBERG R
Citation: U. Jungnelius et al., DACARBAZINE-VINDESINE VERSUS DACARBAZINE-VINDESINE-CISPLATIN IN DISSEMINATED MALIGNANT-MELANOMA - A RANDOMIZED PHASE-III TRIAL, European journal of cancer, 34(9), 1998, pp. 1368-1374
Citation: G. Andersson et al., ORAL IMPLANT REHABILITATION IN IRRADIATED PATIENTS WITHOUT ADJUNCTIVEHYPERBARIC-OXYGEN, The International journal of oral and maxillofacial implants, 13(5), 1998, pp. 647-654
Authors:
EKBERG L
HOLMBERG O
WITTGREN L
BJELKENGREN G
LANDBERG T
Citation: L. Ekberg et al., WHAT MARGINS SHOULD BE ADDED TO THE CLINICAL TARGET VOLUME IN RADIOTHERAPY TREATMENT PLANNING FOR LUNG-CANCER, Radiotherapy and oncology, 48(1), 1998, pp. 71-77
Authors:
BJELKENGREN G
ARONSEN KF
AUGUSTSSON NE
BORGSTROM S
LINDSTROM C
NYLANDER G
Citation: G. Bjelkengren et al., RADIOPROTECTIVE EFFECT OF LOCAL-ADMINISTRATION OF LYSINE-VASOPRESSIN AND TRIGLYCYL-LYSINE-VASOPRESSIN ON THE RECTAL MUCOSA IN RATS, Acta oncologica, 34(4), 1995, pp. 487-492